Wednesday, October 23, 2019

Cadila Healthcare gets USFDA nod for Haloperidol Decanoate injection

Haloperidol is used in the treatment of schizophrenia and for the
control of tics and vocal utterances of Tourette syndrome.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cadila-healthcare-gets-usfda-nod-for-haloperidol-decanoate-injection/articleshow/71735452.cms

No comments:

Post a Comment